2002
DOI: 10.1093/jnen/61.4.368
|View full text |Cite
|
Sign up to set email alerts
|

The Neuronal Migration Defect in Mice with Zellweger Syndrome (Pex5Knockout) is not Caused by the Inactivity of Peroxisomal β-Oxidation

Abstract: The purpose of this study was to investigate whether deficient peroxisomal beta-oxidation is causally involved in the neuronal migration defect observed in Pex5 knockout mice. These mice are models for Zellweger syndrome, a peroxisome biogenesis disorder. Neocortical development was evaluated in mice carrying a partial or complete defect of peroxisomal beta-oxidation at the level of the second enzyme of the pathway, namely, the hydratase-dehydrogenase multifunctional/bifunctional enzymes MFP1/L-PBE and MFP2/D-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
25
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 46 publications
(26 citation statements)
references
References 26 publications
1
25
0
Order By: Relevance
“…The activities of urate oxidase 21 and dihydroxyacetone phosphate acyltransferase 13 were measured in liver homogenates as well as malondialdehyde levels 22 and protein carbonyl content. 23 Glucokinase activity using the continuous assay, 24 pyruvate kinase activity, 25 plasmalogens, 13 and branched chain fatty acids 26 were determined as previously described. Glycogen content was measured via amyloglycosidase digestion followed by glucose oxidase/peroxidase assay for the quantification of glucose.…”
Section: Methodsmentioning
confidence: 99%
“…The activities of urate oxidase 21 and dihydroxyacetone phosphate acyltransferase 13 were measured in liver homogenates as well as malondialdehyde levels 22 and protein carbonyl content. 23 Glucokinase activity using the continuous assay, 24 pyruvate kinase activity, 25 plasmalogens, 13 and branched chain fatty acids 26 were determined as previously described. Glycogen content was measured via amyloglycosidase digestion followed by glucose oxidase/peroxidase assay for the quantification of glucose.…”
Section: Methodsmentioning
confidence: 99%
“…Lipids were extracted from tissues, homogenized in 3.8 ml of CH 3 OH/ CHCl 3 /H 2 O (2:1:0.8), using a Polytron tissue homogenizer, 24 and separated into neutral lipids, fatty acids, and phospholipids by solid phase extraction (Bond Elut NH 2 column, 500 mg; Varian Benelux, Sint-Katelijne-Waver, Belgium). 20,25 Cholesterol, 26 cholesteryl esters, 26 neutral glycerolipids, 27 and phosphorus content of the phospholipid fraction 28 were determined as previously described. The content of DHA in the phospholipid fraction was determined by GC analysis as previously described.…”
Section: Lipid Analysismentioning
confidence: 99%
“…29 Phytanic, pristanic acid, and C 26:0 were quantified by GC-MS analysis in phospholipids and neutral lipids. 20 …”
Section: Lipid Analysismentioning
confidence: 99%
See 2 more Smart Citations